Bioethics, Ltd.
Cash Flow
Last updated:
Cash flow statement presents a set of outflows and inflows of cash within a company through operating, investing and financing activities. Over the last year, operating activities of Bioethics, Ltd. generated cash of -$22,307, which is more than the previous year. Cash used in financing activities reached the amount of $22,150 last year. Net change in cash is therefore -$157.
Cash Flow
| 2014 | -29.86K | 0 | 41.13K |
|---|---|---|---|
| 2015 | -36.98K | -50K | 100K |
| 2016 | -42.32K | 48.57K | 35K |
| 2017 | -71.17K | 0 | 7K |
| 2018 | -43.94K | 0 | 73.92K |
| 2019 | -79.25K | 0 | 56.31K |
| 2020 | -68.69K | 0 | 60.6K |
| 2021 | -27.48K | 0 | 27.55K |
| 2022 | -25.63K | 0 | 25.2K |
| 2023 | -22.30K | 0 | 22.15K |
BOTH Cash Flow Statement (2014 – 2023)
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|
Cash at beginning of period | 295 | 734 | 667 | 8.76K | 31.69K | 1.72K | 65.9K | 24.65K | 11.63K | 359 |
Operating activities | ||||||||||
Net income | -97.14K | -93.20K | -107.18K | -119.19K | -101.91K | -73.53K | -64.22K | -118.62K | -95.56K | -208.19K |
| Adjustments to reconcile net income to cash generated by operating activities: | ||||||||||
Depreciation and amortization | 0 | 2.94K | 226 | 286 | 286 | 285 | 286 | 60 | 0 | 0 |
Stock-based compensation expense | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Deferred income tax benefit | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Changes in operating assets and liabilities: | ||||||||||
Accounts receivable, net | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Inventories | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Accounts payable | 28.13K | 21.66K | 31.65K | 16.16K | 9.44K | 21K | 2.64K | 3.37K | 2.81K | -3.79K |
Cash generated by operating activities | -22.30K | -25.63K | -27.48K | -68.69K | -79.25K | -43.94K | -71.17K | -42.32K | -36.98K | -29.86K |
Investing activities | ||||||||||
Purchases Of Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Investments In Property Plant And Equipment | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -1.42K | 0 | 0 |
Acquisitions Net | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Cash generated by investing activities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 48.57K | -50K | 0 |
Financing activities | ||||||||||
Common Stock Issued | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Payments for dividends | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Repurchases of common stock | 0 | 0 | 0 | 0 | 0 | -10K | 0 | 0 | 0 | 0 |
Repayments of term debt | 22.15K | 0 | -27.55K | -6K | 0 | 0 | 7K | 0 | 100K | 0 |
Cash used in financing activities | 22.15K | 25.2K | 27.55K | 60.6K | 56.31K | 73.92K | 7K | 35K | 100K | 41.13K |
Net Change In Cash | -157 | -439 | 67 | -8.09K | -22.93K | 29.97K | -64.17K | 41.24K | 13.01K | 11.27K |
Cash at end of period | 138 | 295 | 734 | 667 | 8.76K | 31.69K | 1.72K | 65.9K | 24.65K | 11.63K |
| Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source |